Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 592

The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

Open access
Sardu, Celestino, Gambardella, Jessica, Morelli, Marco Bruno, Wang, Xujun, Marfella, Raffaele, Santulli, Gaetano·2020·Journal of Clinical Medicine

Abstract

The symptoms most commonly reported by patients affected by coronavirus disease (COVID-19) include cough, fever, and shortness of breath. However, other major events usually observed in COVID-19 patients (e.g., high blood pressure, arterial and venous thromboembolism, kidney disease, neurologic disorders, and diabetes mellitus) indicate that the virus is targeting the endothelium, one of the largest organs in the human body. Herein, we report a systematic and comprehensive evaluation of both clinical and preclinical evidence supporting the hypothesis that the endothelium is a key target organ in COVID-19, providing a mechanistic rationale behind its systemic manifestations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm9051417

Cites

237 of 237 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 237 references

Research works printed but not linked: 21

  1. Santulli, G., Morelli, M., and Gambardella, J. (2020). Is Endothelial Dysfunction the Concealed Cornerstone of COVID-19?. BMJ, in press.
  2. Vanarsdall, 2018, CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells, mBio, 9, e00781-18, 10.1128/mBio.00781-18 · doi:10.1128/mbio.00781-18
  3. Cai, 2017, Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury, Mol. Med., 23, 92, 10.2119/molmed.2016.00222 · doi:10.2119/molmed.2016.00222
  4. Jakovac, H. (2020). COVID-19-is the ACE2 just a foe?. Am. J. Physiol. Cell. Mol. Physiol. · doi:10.1152/ajplung.00119.2020
  5. Santulli, 2018, Endothelial cells: The heart attack of the Clones, Sci. Transl. Med., 10, eaar7529, 10.1126/scitranslmed.aar7529 · doi:10.1126/scitranslmed.aar7529
  6. Gambardella, J., Sardu, C., and Santulli, G. (2020). COVID-19 and endothelial dysfunction. JAMA, in press.
  7. Talreja, 2020, A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019), N. Z. Med. J., 133, 85
  8. Sunden-Cullberg, J. (2020). Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non-COVID-19 Sepsis but Carry a Moderately Increased Risk of Death. Hypertension. · doi:10.1161/hypertensionaha.120.15178
  9. Xuan, 2018, Activation of ACE2/angiotensin (1-7) attenuates pancreatic beta cell dedifferentiation in a high-fat-diet mouse model, Metabolism, 81, 83, 10.1016/j.metabol.2017.12.003 · doi:10.1016/j.metabol.2017.12.003
  10. Jagroop, 2000, Angiotensin II can induce and potentiate shape change in human platelets: Effect of losartan, J. Hum. Hypertens., 14, 581, 10.1038/sj.jhh.1001102 · doi:10.1038/sj.jhh.1001102
  11. Langeggen, 2001, Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro, Apmis, 109, 73, 10.1111/j.1600-0463.2001.tb00016.x · doi:10.1111/j.1600-0463.2001.tb00016.x
  12. Warren, 1987, The third component of complement is transcribed and secreted by cultured human endothelial cells, Am. J. Pathol., 129, 9
  13. Johnson, 1991, Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro, Scand J. Immunol., 33, 667, 10.1111/j.1365-3083.1991.tb02539.x · doi:10.1111/j.1365-3083.1991.tb02539.x
  14. Xie, 2020, COVID-19 complicated by acute pulmonary embolism, Radiology, 2, e200067
  15. Jolobe, 2019, Similarities Between Community-Acquired Pneumonia and Pulmonary Embolism, Am. J. Med., 132, e863, 10.1016/j.amjmed.2019.03.002 · doi:10.1016/j.amjmed.2019.03.002
  16. Rubin, 2020, Audio Interview: New Research on Possible Treatments for Covid-19, New Engl. J. Med., 382, e30
  17. Luo, 2013, Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function, Basic Res. Cardiol., 108, 342, 10.1007/s00395-013-0342-4 · doi:10.1007/s00395-013-0342-4
  18. Gambardella, J., Morelli, M., Sardu, C., and Santulli, G. (2020). Targeting Endothelial Dysfunction in COVID-19. Nature, in press.
  19. Massamiri, 1991, Sigma receptor ligands inhibit rat tail artery contractile responses by multiple mechanisms, J. Pharmacol. Exp. Ther., 259, 22
  20. Sfikakis, 2007, Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis, Arthritis Rheum., 56, 1985, 10.1002/art.22634 · doi:10.1002/art.22634
  21. Basu, 2007, Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells, J. Virol., 81, 3933, 10.1128/JVI.02622-06 · doi:10.1128/jvi.02622-06

Cited by

See all 592

Metadata

Authors
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G.
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2020-05-11
Volume
9
Issue
5
Pages
1417
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3021377320
Cited by
592
References
237
FWCI
15.99
Type
journal article
Language
en
Open access
gold
Funders
National Institutes of Health (R01-HL146691)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. https://app.cochat.ai/papers/10.3390/jcm9051417
The paper
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020). Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. Journal of Clinical Medicine. https://doi.org/10.3390/jcm9051417

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.